Having trouble accessing articles? Reset your cache.

Endo to acquire Penwest

Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) will acquire partner Penwest Pharmaceuticals Co. (NASDAQ:PPCO) in a tender offer of $5 per share,

Read the full 209 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE